Signaling Pathways - HBV Proteases - CMV - Calcium-Activated Potassium (KCa) Channels - Tie-2
清除全部
-
B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂 -
B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂 -
B2097 Ganciclovir中文名: 更昔洛韦Target: CMVSummary: 针对CMV感染的抗病毒药 -
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂 -
A8458 Lamivudine中文名: 拉米夫定，拉美呋定，拉米呋啶Target: HBV ProteasesSummary: 核苷类似物逆转录酶抑制剂 -
A5979 Tie2 kinase inhibitor中文名: Tie2激酶抑制剂Target: Tie-2Summary: Tie-2(Tie2 )抑制剂 -
A5790 Cidofovir中文名: 西多福韦Target: CMVSummary: 抗CMV药;病毒DNA合成抑制剂 -
A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药